Home Other Building Blocks 2-Hydrazinobenzothiazole

2-Hydrazinobenzothiazole

CAS No.:
615-21-4
Catalog Number:
AG003B8D
Molecular Formula:
C7H7N3S
Molecular Weight:
165.2156
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$64
- +
5g
95%
In Stock USA
United States
$125
- +
Product Description
Catalog Number:
AG003B8D
Chemical Name:
2-Hydrazinobenzothiazole
CAS Number:
615-21-4
Molecular Formula:
C7H7N3S
Molecular Weight:
165.2156
MDL Number:
MFCD30553348
IUPAC Name:
1,3-benzothiazol-2-ylhydrazine
InChI:
InChI=1S/C7H7N3S/c8-10-7-9-5-3-1-2-4-6(5)11-7/h1-4H,8H2,(H,9,10)
InChI Key:
JYSUYJCLUODSLN-UHFFFAOYSA-N
SMILES:
NNc1nc2c(s1)cccc2
EC Number:
210-416-6
UNII:
JS4DO3CU7W
NSC Number:
3271
Properties
Complexity:
142  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
165.036g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
165.214g/mol
Monoisotopic Mass:
165.036g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
79.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.8  
Literature
Title Journal
Design, synthesis and DNA binding activities of late first row transition metal(II) complexes of bi- functional tri - and tetratopic imines. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121101
Application of medical and analytical methods in Lyme borreliosis monitoring. Analytical and bioanalytical chemistry 20120301
2-{(E)-1-[2-(4-Nitro-phen-yl)hydrazin-1-yl-idene]eth-yl}benzene-1,3-diol. Acta crystallographica. Section E, Structure reports online 20120301
2-[(E)-Phen-yl(2-phenyl-hydrazin-1-yl-idene)meth-yl]phenol. Acta crystallographica. Section E, Structure reports online 20120301
Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl)benzothiazole derivatives as anti-tubercular agents. Bioorganic & medicinal chemistry letters 20120101
Phenoxide bridged tetranuclear Co(II), Ni(II), Cu(II) and Zn(II) complexes: electrochemical, magnetic and antimicrobial studies. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901
Bis(μ-2-{[2-(1,3-benzothia-zol-2-yl)hydrazinyl-idene]meth-yl}-6-meth-oxy-phenolato)bis-[dinitratodysprosium(III)] methanol disolvate. Acta crystallographica. Section E, Structure reports online 20110601
Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. European journal of medicinal chemistry 20101101
Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles. European journal of medicinal chemistry 20100901
Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking. Bioorganic & medicinal chemistry letters 20090715
4-{[(1,3-Benzothia-zolium-2-yl)hydra-zono](phen-yl)meth-yl}-3-methyl-1-phenyl-1H-pyrazol-5-olate monohydrate. Acta crystallographica. Section E, Structure reports online 20080401
Synthesis of some new benzothiazole derivatives as potential antimicrobial and antiparasitic agents. Die Pharmazie 20030801
Properties